Why the study?
Do angiotensin II receptor antagonists offer specific pharmacological or clinical advantages over ACE inhibitors in the treatment of cardiovascular disease?
Population
Patients with cardiovascular disease
Comparison
Angiotensin II receptor antagonists vs Angiotensin I converting enzyme (ACE) inhibitors
Design
Review
Authors
Loading...
Potential differences between ARBs and ACEIs remain incompletely defined; leaves open whether ARBs confer specific advantages in cardiovascular disease.
Do angiotensin II receptor antagonists offer specific pharmacological or clinical advantages over ACE inhibitors in the treatment of cardiovascular disease?
This review explores the potential pharmacological and clinical differences between angiotensin II receptor antagonists and ACE inhibitors.
Levens et al. (1992) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: